BREAKING
Zenas BioPharma, Inc. (ZBIO) Reports a Net Loss for Q4 FY25 13 hours ago Dollar Tree, Inc. (DLTR) Beats Q4 Earnings Estimates 13 hours ago CytomX Therapeutics, Inc. (CTMX) Reports Net Loss for FY25 14 hours ago VNET Group, Inc. (VNET) Q4 2025 Revenue Rises 19.6% 14 hours ago VinFast Auto Ltd. (VFS) Reports a Wider Loss for Q4 FY25 15 hours ago Townsquare Media, Inc. (TSQ) Beats Q4 EPS Estimates 15 hours ago Science Applications International (SAIC) Beats Q4 EPS Estimates 15 hours ago Bitcoin Depot Inc. (BTM) Reports Q4 Earnings 15 hours ago NXP Semiconductors (NXPI) Maintains $1.01 Quarterly Dividend, 2.13% Yield With March 25 Ex-Date 17 hours ago Methanex (MEOH) Stock Plunges 10.9% as Q4 Loss of $0.14/Share Misses Estimate by 121.7% 18 hours ago Zenas BioPharma, Inc. (ZBIO) Reports a Net Loss for Q4 FY25 13 hours ago Dollar Tree, Inc. (DLTR) Beats Q4 Earnings Estimates 13 hours ago CytomX Therapeutics, Inc. (CTMX) Reports Net Loss for FY25 14 hours ago VNET Group, Inc. (VNET) Q4 2025 Revenue Rises 19.6% 14 hours ago VinFast Auto Ltd. (VFS) Reports a Wider Loss for Q4 FY25 15 hours ago Townsquare Media, Inc. (TSQ) Beats Q4 EPS Estimates 15 hours ago Science Applications International (SAIC) Beats Q4 EPS Estimates 15 hours ago Bitcoin Depot Inc. (BTM) Reports Q4 Earnings 15 hours ago NXP Semiconductors (NXPI) Maintains $1.01 Quarterly Dividend, 2.13% Yield With March 25 Ex-Date 17 hours ago Methanex (MEOH) Stock Plunges 10.9% as Q4 Loss of $0.14/Share Misses Estimate by 121.7% 18 hours ago
ADVERTISEMENT
Market News

Aptiv Shares Tick Higher After Q4 Results, Eyes Strategic Spin-Off; 2026 Outlook Mixed

Aptiv PLC (NYSE: APTV) shares were trading modestly higher in early U.S. trading, up about 2% intraday. The stock was trading below recent highs seen in early 2025. 52-week range roughly between $47 and $89, reflecting mixed sentiment on growth prospects and structural change. Quarterly Results Aptiv reported Q4 2025 U.S. GAAP revenue of $5.2 […]

February 2, 2026 2 min read

Aptiv PLC (NYSE: APTV) shares were trading modestly higher in early U.S. trading, up about 2% intraday. The stock was trading below recent highs seen in early 2025. 52-week range roughly between $47 and $89, reflecting mixed sentiment on growth prospects and structural change. Quarterly Results Aptiv reported Q4 2025 U.S. GAAP revenue of $5.2 […]

Quarterly Results

Q4 adjusted operating income was $607 million. Q4 adjusted EBITDA was $798 million. Operating cash flow in Q4 reached $818 million.

Adjusted operating margin was 11.8%, down from 12.7% a year earlier, reflecting higher commodity costs and foreign exchange headwinds.

Full-Year Performance

Aptiv reported revenue of $20.4 billion, up 3% on both GAAP and adjusted bases for FY25. GAAP net income was $165 million, including a non-cash goodwill impairment charge of $648 million. Adjusted net income was $1,726 million. Adjusted EPS was $7.82, up from $6.26 in 2024.

Full year adjusted operating income was $2,461 million, with an adjusted operating margin of 12.1%, slightly above the prior year.

Strategic Spin-Off

Aptiv reiterated its plan to spin off its Electrical Distribution Systems (EDS) business as a separate publicly traded entity, Versigent, expected in mid-2026, aiming to create two focused companies with distinct strategic priorities and capital allocation frameworks.

In connection with the spin-off, Aptiv will rename reporting segments: its Advanced Safety and User Experience segment becomes Intelligent Systems and Engineered Components Group becomes Engineered Components.

2026 Outlook

Aptiv provided Q1 and FY26 guidance. For Q1 2026, Aptiv expects net sales of $4.95 billion–$5.15 billion, adjusted EPS of $1.55–$1.75, and adjusted EBITDA margin around 14.7%.

For FY26 on a pro-forma basis post spin-off, the combined entity is projected to deliver $21.12 billion–$21.82 billion in net sales and adjusted EPS of $8.15–$8.75; the New Aptiv standalone is expected to post $12.8 billion–$13.2 billion in revenues with adjusted EPS of $5.70–$6.10.

Analyst Activity

No major analyst upgrades, downgrades or price-target changes. Mixed market reaction with some volatility reflecting investor focus on guidance and the spin-off execution.

Market Context

Aptiv’s results underscore moderate top-line growth amid challenging supply conditions in Europe and Asia, offset by stronger performance in the Americas. The strategic repositioning via the EDS spin-off remains a core focus for investor attention in 2026 trading.

ADVERTISEMENT